7-Dehydrocholesterol Reductase (DHCR7) Antibody

Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
7-Dehydrocholesterol Reductase (DHCR7) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx341675
tested applications
ELISA, WB, IHC

Description

7-Dehydrocholesterol Reductase (DHCR7) Antibody is a Rabbit Polyclonal antibody for the detection of Human DHCR7.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
7-Dehydrocholesterol Reductase (DHCR7)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G chromatography.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9UBM7
Background
Antibody anti-DHCR7
Status
RUO

Descripción

Related Products

EH13908

Human DHCR7 (7-dehydrocholesterol reductase) ELISA Kit

Ver Producto
abx006601

7-Dehydrocholesterol Reductase (DHCR7) Antibody

DHCR7 Antibody is a Rabbit Polyclonal Antibody against DHCR7.

Ver Producto
abx026271

7-Dehydrocholesterol Reductase (DHCR7) Antibody

This gene encodes an enzyme that removes the C (7-8) double bond in the B ring of sterols and catalyzes the conversion of 7-dehydrocholesterol to cholesterol. This gene is ubiquitously expressed and its transmembrane protein localizes to the endoplasmic reticulum membrane and nuclear outer membrane. Mutations in this gene cause Smith-Lemli-Opitz syndrome (SLOS) ; a syndrome that is metabolically characterized by reduced serum cholesterol levels and elevated serum 7-dehydrocholesterol levels and phenotypically characterized by mental retardation, facial dysmorphism, syndactyly of second and third toes, and holoprosencephaly in severe cases to minimal physical abnormalities and near-normal intelligence in mild cases. Alternative splicing results in multiple transcript variants that encode the same protein.

Ver Producto